Search

Abstract Background This study aims to assess the efficacy and safety of Qingpeng ointment (QPO), a Tibetan medicine for alleviating symptoms in individuals with acute gouty arthritis (AGA). Methods This study was a randomized, double-blind, placebo-controlled trial that involved individuals with AGA whose joint pain, as measured on a visual analog scale (VAS) from 0 to 10, was equal to or greater than 3. The participants were randomly assigned to either the QPO or the placebo group and received their respective treatments twice daily for seven consecutive days. In case of intolerable pain, the participants were allowed to use diclofenac sodium sustained-release tablets as a rescue medicine. The primary outcomes measured were joint pain and swelling, while the secondary outcomes included joint mobility, redness, serum uric acid levels, C-reactive protein levels, and the amount of remaining rescue medicine. Any adverse events that occurred during the trial were also recorded. Results A total of 203 cases were divided into two groups, with balanced baselines: 102 in the QPO group and 101 in the placebo group. For joint pain, differences between the groups were notable in the VAS scores [1.75 (0, 3.00) versus 2.00 (1.00, 3.50); P = 0.038], changes in VAS [5.00 (3.00, 6.00) versus 4.00 (2.00, 6.00); P = 0.036], and disappearance rate [26.47% compared to 15.84%; P = 0.046] after treatment. Concerning joint swelling, significant between-group differences were observed in the VAS scores [1.00 (0, 2.30) versus 2.00 (0.70, 3.00); P = 0.032] and disappearance rate [33.33% compared to 21.78%; P = 0.046] at treatment completion. The QPO group exhibited a statistically significant mobility improvement compared to the placebo group (P = 0.004). No significant differences were found in other secondary outcomes. Five patients, four from the QPO group and one from the other, encountered mild adverse events, primarily skin irritation. All of these cases were resolved after dosage reduction or discontinuation of the medication. Conclusions Compared to the placebo, QPO exhibits positive effects on AGA by alleviating pain, reducing swelling, and enhancing joint mobility, without causing significant adverse effects. Trial Registration ISRCTN34355813. Registered on 25/01/2021.

Abstract Background Acute gouty arthritis (AGA) is an inflammatory arthritis clinically characterized by severe pain, swelling, and restricted movement of joints, which may cause physical disability and decrease quality of life. The use of recommended first-line treatment agents for AGA may be limited by adverse events. There has been a traditional use of alternative therapies for AGA. Tibetan medicine Qingpeng ointment is one of the on-market herbal products used for symptom relief of AGA. Previous clinical studies indicated that Qingpeng ointment can relieve pain, swelling, redness, and dysfunction of joints in patients with AGA. However, there is no rigorous randomized trial to demonstrate its benefit for AGA. In order to evaluate the efficacy and safety of Qingpeng ointment for AGA, we designed a randomized controlled trial. Methods This study is designed as a multi-center, randomized, double-blind, placebo-controlled trial. Two hundred and six adults with acute flare of gout, and visual analogue scale (VAS) score of joint pain ≥ 3 points will be recruited. Participants will be randomly assigned to herbal treatment or placebo group at a ratio of 1:1. Qingpeng ointment, or equal placebo ointment, will be applied topically at involved joints twice a day for consecutive 7 days. Patients in both groups would be allowed giving diclofenac sodium sustained-release tablets as rescue therapy when VAS score of joint pain ≥ 7 points during the treatment. The primary outcomes will be joint pain measured by VAS score, and joint swelling measured using width and thickness of affected joints and VAS score. Other outcome measures will be joint mobility, joint redness, C-reactive protein, serum uric acid, and the use of rescue medicine as well as adverse effect. Discussion To the best of our knowledge, this study is the first multi-center, randomized, double-blind, and placebo-controlled clinical trial to assess the efficacy of Tibetan medicine Qingpeng ointment for AGA. The findings of this study would provide evidence for its use to relieve symptoms of AGA. Trial registration ISRCTN ISRCTN34355813 . Registered on 25 January 2021

Abstract Interfacial host–guest complexation offers a versatile way to functionalize nanomaterials. However, the complicated interfacial environment and trace amounts of components present at the interface make the study of interfacial complexation very difficult. Herein, taking the advantages of near-single-molecule level sensitivity and molecular fingerprint of surface-enhanced Raman spectroscopy (SERS), we reveal that a cooperative effect between cucurbit[7]uril (CB[7]) and methyl viologen (MV2+2I−) in aggregating Au NPs originates from the cooperative adsorption of halide counter anions I−, MV2+, and CB[7] on Au NPs surface. Moreover, similar SERS peak shifts in the control experiments using CB[n]s but with smaller cavity sizes suggested the occurrence of the same guest complexations among CB[5], CB[6], and CB[7] with MV2+. Hence, an unconventional exclusive complexation model is proposed between CB[7] and MV2+ on the surface of Au NPs, distinct from the well-known 1:1 inclusion complexation model in aqueous solutions. In summary, new insights into the fundamental understanding of host–guest interactions at nanostructured interfaces were obtained by SERS, which might be useful for applications related to host–guest chemistry in engineered nanomaterials.

Covalently bridged π-stacked dimers are excellent molecular platforms for understanding the relationship between stacking orientation and properties. Here, the authors synthesize a pair of π-stacked dimers that are aligned either cofacially or crosswise, allowing them to compare how the intramolecular stacking mode affects each dimer’s photoswitching properties.

Traditional Chinese medicine (TCM) has been used successfully to treat rheumatoid arthritis (RA). Qingre Huoxue treatment (Qingre Huoxue decoction (QRHXD)/Qingre Huoxue external preparation (QRHXEP)) is a therapeutic scheme of TCM for RA. To date, there have been few studies comparing the efficacy and safety of QRHXD and conventional synthetic disease-modifying antirheumatic drugs (csDMARDs) for the treatment of active RA. This was investigated in a multicenter, double-blind, randomized controlled trial involving 468 Chinese patients with active RA [disease activity score (DAS)-28 > 3.2] treated with QRHXD/QRHXEP (TCM group), methotrexate plus hydroxychloroquine [Western medicine (WM) group], or both [integrative medicine (IM) group]. Patients were followed up for 24 weeks. The primary outcome measure was the change in DAS-28 from baseline to 24 weeks. The secondary outcome measures were treatment response rate according to American College of Rheumatology 20, 50, and 70% improvement criteria (ACR-20/50/70) and the rate of treatment-related adverse events (TRAEs). The trial was registered at ClinicalTrials.gov (NCT02551575). DAS-28 decreased in all three groups after treatment (p < 0.0001); the score was lowest in the TCM group (p < 0.05), while no difference was observed between the WM and IM groups (p > 0.05). At week 24, ACR-20 response was 73.04% with TCM, 80.17% with WM, and 73.95% with IM (based on the full analysis set [FAS], p > 0.05); ACR-50 responses were 40.87, 47.93, and 51.26%, respectively, (FAS, p > 0.05); and ACR-70 responses were 20.87, 22.31, and 25.21%, respectively, (FAS, p > 0.05). Thus, treatment efficacy was similar across groups based on ACR criteria. On the other hand, the rate of TRAEs was significantly lower in the TCM group compared to the other groups (p < 0.05). Thus, QRHXD/QRHXEP was effective in alleviating the symptoms of active RA—albeit to a lesser degree than csDMARDs—with fewer side effects. Importantly, combination with QRHXD enhanced the efficacy of csDMARDs. These results provide evidence that QRHXD can be used as an adjunct to csDMARDs for the management of RA, especially in patients who experience TRAEs with standard drugs.Clinical Trial Registration: ClinicalTrials.gov, identifier NCTNCT025515.

Abstract Lower surface roughness and sharper cutting edge are beneficial for improving the machining quality of the cutting tool, while coatings often deteriorate them. Focusing on the diamond coated WC-Co milling cutter, the abrasive flow machining (AFM) is selected for reducing the surface roughness and sharpening the cutting edge. Comparative cutting tests are conducted on different types of coated cutters before and after AFM, as well as uncoated WC-Co one, demonstrating that the boron-doped microcrystalline and undoped fine-grained composite diamond coated cutter after the AFM (AFM-BDM-UFGCD) is a good choice for the finish milling of the 6063 Al alloy in the present case, because it shows favorable machining quality close to the uncoated one, but much prolonged tool lifetime. Besides, compared with the micro-sized diamond films, it is much more convenient and efficient to finish the BDM-UFGCD coated cutter covered by nano-sized diamond grains, and resharpen its cutting edge by the AFM, owing to the lower initial surface roughness and hardness. Moreover, the boron incorporation and micro-sized grains in the underlying layer can enhance the film-substrate adhesion, avoid the rapid film removal in the machining process, and thus maximize the tool life (1040 m, four times more than the uncoated one). In general, the AFM is firstly proposed and discussed for post-processing the diamond coated complicated cutting tools, which is proved to be feasible for improving the cutting performance

In this paper, the approximation property of the linear combinations of Baskakov operators is investigated by using a Jacobi weight function. Moreover, both the positive and inverse theorems for the weighted simultaneous approximation of the linear combinations of Baskakov operators are proved.

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Hierarchical composite films grown on current collectors are popularly reported to be directly used as electrodes for supercapacitors. Highly dense and conductive NiCo2O4 nanowires are ideal backbones to support guest materials. In this work, low crystalline MnO2 nanoflakes are electrodeposited onto the surface of NiCo2O4 nanowire films pre-coated on nickel foam. Each building block in the composite films is a NiCo2O4−MnO2 core−shell nanowire on conductive nickel foam. Due to the co-presence of MnO2 and NiCo2O4, the MnO2@NiCo2O4@Ni electrode exhibits higher specific capacitance and larger working voltage than the NiCo2O4@Ni electrode. It can have a high specific capacitance of 1186 F·g−1 at 1 A·g−1. When the core−shell NiCo2O4−MnO2 composite and activated carbon are assembled as a hybrid capacitor, it has the highest energy density of 29.6 Wh·kg−1 at a power density of 425 W·kg−1 with an operating voltage of 1.7 V. This work shows readers an easy method to synthesize composite films for energy storage.

The research on supercapacitors has been attractive due to their large power density, fast charge/discharge speed and long lifespan. The electrode materials for supercapacitors are thus intensively investigated to improve the electrochemical performances. Various transition metal layered double hydroxides (LDHs) with a hydrotalcite-like structure have been developed to be promising electrode materials. Earth-abundant metal hydroxides are very suitable electrode materials due to the low cost and high specific capacity. This is a review paper on NiMn LDHs for supercapacitor application. We focus particularly on the recent published papers using NiMn LDHs as electrode materials for supercapacitors. The preparation methods for NiMn LDHs are introduced first. Then, the structural design and chemical modification of NiMn LDH materials, as well as the composites and films derived from NiMn LDHs are discussed. These approaches are proven to be effective to enhance the performance of supercapacitor. Finally, the reports related to NiMn LDH-based asymmetric supercapacitors are summarized. A brief discussion of the future development of NiMn LDHs is also provided.

The synthesis of 11a,25a-dibora-11,12,25,26-tetraoxatetranaphtho[1,2-a:2',1'-f:1",2"-j:2'",1'"-o]perylene, a double [7]heterohelicene containing OBO units, has been achieved via tandem demethylation-borylation, representing the highest double helicene reported thus far with all six-membered rings. Single-crystal X-ray analysis clearly demonstrated a significantly twisted structure with the terminal aromatic rings overlapping at both ends, giving the first example of a double helicene with intramolecular π-layers. Such structural features resulted in a high theoretical isomerization barrier of 45.1 kcal/mol, which is the highest value for all the double helicenes ever reported, rendering the achieved molecule with high chiral stability. The (P,P)- and (M,M)-isomers were separated by chiral HPLC and the chiroptical properties were investigated, revealing opposite circular dichroism responses. [ABSTRACT FROM AUTHOR]